Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.
JAMA Neurol
; 78(12): 1510-1514, 2021 12 01.
Article
in En
| MEDLINE
| ID: mdl-34554197
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Immunity, Humoral
/
Antibodies, Monoclonal, Humanized
/
COVID-19 Vaccines
/
Immunologic Factors
/
Multiple Sclerosis
Type of study:
Guideline
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
JAMA Neurol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: